-
1
-
-
0037501364
-
Incidence of tardive dyskinesia with typical versus atypical antipsychotics in very high risk patients
-
Dolder, C.R., and Jeste, D.V. Incidence of tardive dyskinesia with typical versus atypical antipsychotics in very high risk patients. Biological Psychiatry, 53(12): 1142-1145, 2003.
-
(2003)
Biological Psychiatry
, vol.53
, Issue.12
, pp. 1142-1145
-
-
Dolder, C.R.1
Jeste, D.V.2
-
2
-
-
0036305380
-
Patients' subjective experiences of antipsychotics: Clinical relevance
-
Hellewell, J.S. Patients' subjective experiences of antipsychotics: Clinical relevance. CNS Drugs, 16(7):457-471, 2002.
-
(2002)
CNS Drugs
, vol.16
, Issue.7
, pp. 457-471
-
-
Hellewell, J.S.1
-
3
-
-
1542270909
-
The Schizophrenia Patient Outcomes Research Team (PORT): Updated treatment recommendations 2003
-
Lehman, A.F.; Kreyenbuhl, J.; Buchanan, R.W.; Dickerson, F.B.; Dixon, L.B.; Goldberg, R.; Green-Paden, L.D.; Tenhula, W.N.; Boerescu, D.; Tek, C.; Sandson, N.; and Steinwachs, D.M. The Schizophrenia Patient Outcomes Research Team (PORT): Updated treatment recommendations 2003. Schizophrenia Bulletin, 30(2): 193-217, 2004a.
-
(2004)
Schizophrenia Bulletin
, vol.30
, Issue.2
, pp. 193-217
-
-
Lehman, A.F.1
Kreyenbuhl, J.2
Buchanan, R.W.3
Dickerson, F.B.4
Dixon, L.B.5
Goldberg, R.6
Green-Paden, L.D.7
Tenhula, W.N.8
Boerescu, D.9
Tek, C.10
Sandson, N.11
Steinwachs, D.M.12
-
4
-
-
1642283731
-
Practice guideline for the treatment of patients with schizophrenia, second edition
-
Lehman, A.F.; Lieberman, J.A.; Dixon, L.B.; McGlashan, T.H.; Miller, A.L.; Perkins, D.O.; Kreyenbuhl, J.; American Psychiatric Association; Steering Committee on Practice Guidelines. Practice guideline for the treatment of patients with schizophrenia, second edition. American Journal of Psychiatry, 161(2 Suppl):1-56, 2004b.
-
(2004)
American Journal of Psychiatry
, vol.161
, Issue.2 SUPPL.
, pp. 1-56
-
-
Lehman, A.F.1
Lieberman, J.A.2
Dixon, L.B.3
McGlashan, T.H.4
Miller, A.L.5
Perkins, D.O.6
Kreyenbuhl, J.7
-
5
-
-
0035988520
-
The Mount Sinai Conference on the pharmacotherapy of schizophrenia
-
Marder, S.R.; Essock, S.M.; Miller, A.L.; Buchanan, R.W.; Davis, J.M.; Kane, J.M.; Lieberman, J.A.; and Schooler, N.R. The Mount Sinai Conference on the pharmacotherapy of schizophrenia. Schizophrenia Bulletin, 28(1):5-16, 2002.
-
(2002)
Schizophrenia Bulletin
, vol.28
, Issue.1
, pp. 5-16
-
-
Marder, S.R.1
Essock, S.M.2
Miller, A.L.3
Buchanan, R.W.4
Davis, J.M.5
Kane, J.M.6
Lieberman, J.A.7
Schooler, N.R.8
-
6
-
-
2442473932
-
The Texas Medication Algorithm Project antipsychotic algorithm for schizophrenia: 2003 Update
-
Miller, A.L.; Hall, C.S.; Buchanan, R.W.; Buckley, P.F.; Chiles, J.A.; Conley, R.R.; Crismon, M.L.; Ereshefsky, L.; Essock, S.M.; Finnerty, M.; Marder, S.R.; Miller, D.; McEvoy, J.; Rush, A.J.; Saeed, S.A.; Schooler, N.R.; Shon, S.P.; Stroup, S.; and Tarin-Godoy, B. The Texas Medication Algorithm Project antipsychotic algorithm for schizophrenia: 2003 update. Journal of Clinical Psychiatry, 65(4):500-508, 2004.
-
(2004)
Journal of Clinical Psychiatry
, vol.65
, Issue.4
, pp. 500-508
-
-
Miller, A.L.1
Hall, C.S.2
Buchanan, R.W.3
Buckley, P.F.4
Chiles, J.A.5
Conley, R.R.6
Crismon, M.L.7
Ereshefsky, L.8
Essock, S.M.9
Finnerty, M.10
Marder, S.R.11
Miller, D.12
McEvoy, J.13
Rush, A.J.14
Saeed, S.A.15
Schooler, N.R.16
Shon, S.P.17
Stroup, S.18
Tarin-Godoy, B.19
|